BP000050-GD13: Recombinant Human RANKL Protein
Source:E. coli-derived.
The RANKL / TNFSF11 / TRANCE / OPGL / CD254 activity is calculated by its ability to induce osteoclast differentiation on RAW 264.7 mouse macrophages. The ED50 for this effect is 2-12 ng/ml.
Endotoxin Level: <1.0 EU per ug of the protein by the LAL method.
Purity > 95%, by SDS-PAGE and SEC-HPLC.BP000173-CYT-320: Recombinant Mouse RANK Ligand Soluble
Source: E. coli-derived.
A single, non-glycosylated, polypeptide chain containing 174 amino acids and having a total molecular mass of 19.9 kDa.
Measured by its ability to induce osteoclast formation on murine RAW264.7 cells using a concentration of 5.0-10.0 ug/ml, corresponding to a specific activity of 100,000-200,000 Units/mg.
Purity > 95%, by SDS-PAGE and RP-HPLC.BP000173-CYT-334: Recombinant Human RANK Ligand Soluble
Source: E. coli-derived.
A single, non-glycosylated polypeptide chain containing 176 amino acids and having a molecular mass of 20006 Dalton.
The activity as determined by its ability to induce a dose dependant stimulation of IL-8 production in human PBMCs, is 39-51 ug/ml.
Purity > 98%, by SDS-PAGE and RP-HPLC.BP000173-CYT-631: Recombinant Human Soluble RANK Ligand, GST tag
Source: E. coli-derived.
A single, non-glycosylated polypeptide chain containing 176 amino acids and having a molecular mass of 20006 Dalton.
Purity > 95%, by SDS-PAGE.
BP000173-CYT-692: Recombinant Human Soluble RANK Ligand, His Tag
Source: E. coli-derived.
Purity > 80%, by SDS-PAGE.BP003056: Recombinant SARS-CoV-2 Spike S1-Fc-Avi Protein (S Protein S1 Subunit)
Source: mammalian cells.
Activity: Immobilized recombinant human ACE2, His Tag at 0.5 ug/ml (100 ul/well). Dose response curve for the recombinant SARS-CoV-2 Spike S1-Fc-Avi protein with the EC50 of 0.1 ug/ml determined by ELISA.
Purity: > 95% by PAGE under reduced condition, and SEC-HPLC.